Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Beauchamp

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Breast Cancer Research and Treatment|January 5, 2021
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug targetJohn R Mackey, Justine Lai, Utkarsh Chauhan, et al.
Molecular Cancer Therapeutics|October 9, 2024
Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia CellsJay M Gamma, Qiang Liu, Erwan Beauchamp, et al.
Journal of Translational Medicine|May 7, 2024
Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibitionErwan Beauchamp, Jay M Gamma, Christopher R Cromwell, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Breast Cancer Research and Treatment|January 5, 2021
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug targetJohn R Mackey, Justine Lai, Utkarsh Chauhan, et al.
Molecular Cancer Therapeutics|October 9, 2024
Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia CellsJay M Gamma, Qiang Liu, Erwan Beauchamp, et al.
Journal of Translational Medicine|May 7, 2024
Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibitionErwan Beauchamp, Jay M Gamma, Christopher R Cromwell, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Pageof 3